Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1992 Jul;45(7):556–560. doi: 10.1136/jcp.45.7.556

Chromosome studies of solid tumours.

N P Bown 1
PMCID: PMC495176  PMID: 1517454

Full text

PDF
556

Images in this article

557Image
on p.557
558Image
on p.558
558Image
on p.558

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alimena G., De Cuia M. R., Diverio D., Gastaldi R., Nanni M. The karyotype of blastic crisis. Cancer Genet Cytogenet. 1987 May;26(1):39–50. doi: 10.1016/0165-4608(87)90131-2. [DOI] [PubMed] [Google Scholar]
  2. Arnoldus E. P., Noordermeer I. A., Peters A. C., Voormolen J. H., Bots G. T., Raap A. K., van der Ploeg M. Interphase cytogenetics of brain tumors. Genes Chromosomes Cancer. 1991 Mar;3(2):101–107. doi: 10.1002/gcc.2870030204. [DOI] [PubMed] [Google Scholar]
  3. Atkin N. B., Baker M. C. Squamous cell carcinomas of the head, neck, and skin. Monoclonal or polyclonal origin? Cancer Genet Cytogenet. 1991 Jul 1;54(1):135–136. doi: 10.1016/0165-4608(91)90043-t. [DOI] [PubMed] [Google Scholar]
  4. Barrios L., Miró R., Caballín M. R., Fuster C., Guedea F., Subias A., Egozcue J. Cytogenetic effects of radiotherapy. Breakpoint distribution in induced chromosome aberrations. Cancer Genet Cytogenet. 1989 Aug;41(1):61–70. doi: 10.1016/0165-4608(89)90108-8. [DOI] [PubMed] [Google Scholar]
  5. Bigner S. H., Mark J., Friedman H. S., Biegel J. A., Bigner D. D. Structural chromosomal abnormalities in human medulloblastoma. Cancer Genet Cytogenet. 1988 Jan;30(1):91–101. doi: 10.1016/0165-4608(88)90096-9. [DOI] [PubMed] [Google Scholar]
  6. Bourhis J., De Vathaire F., Wilson G. D., Hartmann O., Terrier-Lacombe M. J., Boccon-Gibod L., McNally N. J., Lemerle J., Riou G., Bénard J. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma. Cancer Res. 1991 Jan 1;51(1):33–36. [PubMed] [Google Scholar]
  7. Brodeur G. M., Seeger R. C. Gene amplification in human neuroblastomas: basic mechanisms and clinical implications. Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):101–111. doi: 10.1016/0165-4608(86)90377-8. [DOI] [PubMed] [Google Scholar]
  8. Christiansen H., Lampert F. Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma. Br J Cancer. 1988 Jan;57(1):121–126. doi: 10.1038/bjc.1988.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cowell J. K. Double minutes and homogeneously staining regions: gene amplification in mammalian cells. Annu Rev Genet. 1982;16:21–59. doi: 10.1146/annurev.ge.16.120182.000321. [DOI] [PubMed] [Google Scholar]
  10. Cowell J. K. The genetics of retinoblastoma. Br J Cancer. 1991 Mar;63(3):333–336. doi: 10.1038/bjc.1991.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cowell J., Pritchard J. The molecular genetics of retinoblastoma and Wilms' tumor. Crit Rev Oncol Hematol. 1987;7(2):153–168. doi: 10.1016/s1040-8428(87)80024-0. [DOI] [PubMed] [Google Scholar]
  12. Donner L. R. Cytogenetics and molecular biology of small round-cell tumors and related neoplasms. Current status. Cancer Genet Cytogenet. 1991 Jul 1;54(1):1–10. doi: 10.1016/0165-4608(91)90023-n. [DOI] [PubMed] [Google Scholar]
  13. Elfving P., Cigudosa J. C., Lundgren R., Limon J., Mandahl N., Kristoffersson U., Heim S., Mitelman F. Trisomy 7, trisomy 10, and loss of the Y chromosome in short-term cultures of normal kidney tissue. Cytogenet Cell Genet. 1990;53(2-3):123–125. doi: 10.1159/000132910. [DOI] [PubMed] [Google Scholar]
  14. Friend S. H., Dryja T. P., Weinberg R. A. Oncogenes and tumor-suppressing genes. N Engl J Med. 1988 Mar 10;318(10):618–622. doi: 10.1056/NEJM198803103181007. [DOI] [PubMed] [Google Scholar]
  15. Griffin C. A., Hawkins A. L., Packer R. J., Rorke L. B., Emanuel B. S. Chromosome abnormalities in pediatric brain tumors. Cancer Res. 1988 Jan 1;48(1):175–180. [PubMed] [Google Scholar]
  16. Haluska F. G., Tsujimoto Y., Croce C. M. Oncogene activation by chromosome translocation in human malignancy. Annu Rev Genet. 1987;21:321–345. doi: 10.1146/annurev.ge.21.120187.001541. [DOI] [PubMed] [Google Scholar]
  17. Hayashi Y., Hanada R., Yamamoto K., Bessho F. Chromosome findings and prognosis in neuroblastoma. Cancer Genet Cytogenet. 1987 Nov;29(1):175–177. doi: 10.1016/0165-4608(87)90047-1. [DOI] [PubMed] [Google Scholar]
  18. Heim S., Jin Y., Mandahl N., Biörklund A., Wennerberg J., Jonsson N., Mitelman F. Multiple unrelated clonal chromosome abnormalities in an in situ squamous cell carcinoma of the skin. Cancer Genet Cytogenet. 1988 Dec;36(2):149–153. doi: 10.1016/0165-4608(88)90137-9. [DOI] [PubMed] [Google Scholar]
  19. Heim S., Mandahl N., Jin Y., Strömblad S., Lindström E., Salford L. G., Mitelman F. Trisomy 7 and sex chromosome loss in human brain tissue. Cytogenet Cell Genet. 1989;52(3-4):136–138. doi: 10.1159/000132863. [DOI] [PubMed] [Google Scholar]
  20. Jenkins R. B., Kimmel D. W., Moertel C. A., Schultz C. G., Scheithauer B. W., Kelly P. J., Dewald G. W. A cytogenetic study of 53 human gliomas. Cancer Genet Cytogenet. 1989 Jun;39(2):253–279. doi: 10.1016/0165-4608(89)90192-1. [DOI] [PubMed] [Google Scholar]
  21. Kaneko Y., Kanda N., Maseki N., Sakurai M., Tsuchida Y., Takeda T., Okabe I., Sakurai M. Different karyotypic patterns in early and advanced stage neuroblastomas. Cancer Res. 1987 Jan 1;47(1):311–318. [PubMed] [Google Scholar]
  22. Knuutila S., Teerenhovi L. Immunophenotyping of aneuploid cells. Cancer Genet Cytogenet. 1989 Aug;41(1):1–17. doi: 10.1016/0165-4608(89)90103-9. [DOI] [PubMed] [Google Scholar]
  23. Mertens F., Heim S., Jin Y. S., Johansson B., Mandahl N., Biörklund A., Wennerberg J., Jonsson N., Mitelman F. Basosquamous papilloma. A benign epithelial skin tumor with multiple cytogenetic clones. Cancer Genet Cytogenet. 1989 Feb;37(2):235–239. doi: 10.1016/0165-4608(89)90054-x. [DOI] [PubMed] [Google Scholar]
  24. Miller D. M., Blume S., Borst M., Gee J., Polansky D., Ray R., Rodu B., Shrestha K., Snyder R., Thomas S. Oncogenes, malignant transformation, and modern medicine. Am J Med Sci. 1990 Jul;300(1):59–69. doi: 10.1097/00000441-199007000-00013. [DOI] [PubMed] [Google Scholar]
  25. Nederlof P. M., van der Flier S., Raap A. K., Tanke H. J., van der Ploeg M., Kornips F., Geraedts J. P. Detection of chromosome aberrations in interphase tumor nuclei by nonradioactive in situ hybridization. Cancer Genet Cytogenet. 1989 Oct 1;42(1):87–98. doi: 10.1016/0165-4608(89)90011-3. [DOI] [PubMed] [Google Scholar]
  26. Nowell P. C. Cytogenetics of tumor progression. Cancer. 1990 May 15;65(10):2172–2177. doi: 10.1002/1097-0142(19900515)65:10<2172::aid-cncr2820651003>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  27. Pérez A., Solé F., Caballín R., Tarrida N., Woessner S. G-banding improvement for the MAC method. Cancer Genet Cytogenet. 1991 Jan;51(1):41–44. doi: 10.1016/0165-4608(91)90006-g. [DOI] [PubMed] [Google Scholar]
  28. Rowley J. D. Molecular cytogenetics: Rosetta stone for understanding cancer--twenty-ninth G. H. A. Clowes memorial award lecture. Cancer Res. 1990 Jul 1;50(13):3816–3825. [PubMed] [Google Scholar]
  29. Rowley J. D. The Philadelphia chromosome translocation. A paradigm for understanding leukemia. Cancer. 1990 May 15;65(10):2178–2184. doi: 10.1002/1097-0142(19900515)65:10<2178::aid-cncr2820651004>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  30. Sandberg A. A., Turc-Carel C., Gemmill R. M. Chromosomes in solid tumors and beyond. Cancer Res. 1988 Mar 1;48(5):1049–1059. [PubMed] [Google Scholar]
  31. Sandberg A. A., Turc-Carel C. The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology. Cancer. 1987 Feb 1;59(3):387–395. doi: 10.1002/1097-0142(19870201)59:3<387::aid-cncr2820590306>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  32. Sawyer J. R., Swanson C. M., Chadduck W. M., Roloson G. J. Evolution of tumor chromosome abnormalities after therapy in a pediatric astrocytoma. Cancer Genet Cytogenet. 1991 May;53(1):119–123. doi: 10.1016/0165-4608(91)90123-c. [DOI] [PubMed] [Google Scholar]
  33. Schouten H. C., Sanger W. G., Weisenburger D. D., Anderson J., Armitage J. O. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. Blood. 1990 May 1;75(9):1841–1847. [PubMed] [Google Scholar]
  34. Secker-Walker L. M., Chessells J. M., Stewart E. L., Swansbury G. J., Richards S., Lawler S. D. Chromosomes and other prognostic factors in acute lymphoblastic leukaemia: a long-term follow-up. Br J Haematol. 1989 Jul;72(3):336–342. doi: 10.1111/j.1365-2141.1989.tb07713.x. [DOI] [PubMed] [Google Scholar]
  35. Selleri L., Hermanson G. G., Eubanks J. H., Lewis K. A., Evans G. A. Molecular localization of the t(11;22)(q24;q12) translocation of Ewing sarcoma by chromosomal in situ suppression hybridization. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):887–891. doi: 10.1073/pnas.88.3.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Teyssier J. R., Ferre D. Frequent clonal chromosomal changes in human non-malignant tumors. Int J Cancer. 1989 Nov 15;44(5):828–832. doi: 10.1002/ijc.2910440514. [DOI] [PubMed] [Google Scholar]
  37. Trent J., Crickard K., Gibas Z., Goodacre A., Pathak S., Sandberg A. A., Thompson F., Whang-Peng J., Wolman S. Methodologic advances in the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet. 1986 Jan 1;19(1-2):57–66. doi: 10.1016/0165-4608(86)90372-9. [DOI] [PubMed] [Google Scholar]
  38. Wang-Wuu S., Soukup S., Ballard E., Gotwals B., Lampkin B. Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res. 1988 Feb 15;48(4):983–987. [PubMed] [Google Scholar]
  39. Whang-Peng J., Triche T. J., Knutsen T., Miser J., Kao-Shan S., Tsai S., Israel M. A. Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet. 1986 Apr 1;21(3):185–208. doi: 10.1016/0165-4608(86)90001-4. [DOI] [PubMed] [Google Scholar]
  40. Yunis J. J., Lobell M., Arnesen M. A., Oken M. M., Mayer M. G., Rydell R. E., Brunning R. D. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. Br J Haematol. 1988 Feb;68(2):189–194. doi: 10.1111/j.1365-2141.1988.tb06188.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES